Andrew Arndt to Risk Assessment
This is a "connection" page, showing publications Andrew Arndt has written about Risk Assessment.
Connection Strength
0.030
-
Serum Biomarkers May Prognosticate Recurrence in Node-Negative, Non-Small Cell Lung Cancers Less Than 4 Centimeters. Ann Thorac Surg. 2017 Nov; 104(5):1637-1643.
Score: 0.030